by Sam Collins | June 12, 2012 1:55 am
Walgreen Co. (NYSE:WAG[1]) — This is the largest revenue producer among the U.S. retail drug chains. But ever since it ended its relationship with Express Scripts in 2011, it has been in a decline.
Sales leverage has been running behind other drug chains, and the company will likely experience very low sales growth in the future. Earnings for fiscal year 2012 are estimated at $2.76, down from $2.94 in 2011.
Technically WAG appeared to be consolidating within a rectangle until it broke through its 50-day moving average and support line in May.
The recent rally could take the stock back to its 50-day at $33 where it should be sold since the current pattern is that of a bearish horn — one of the most feared technical patterns.
A penetration through the lower support line at about $29 targets the stock for a fall to $22.

Source URL: http://investorplace.com/2012/06/trade-of-the-day-walgreen-co-nyse-wag-2/
Short URL: http://investorplace.com/?p=181444
Copyright ©2013 InvestorPlace Media, LLC. All rights reserved. 700 Indian Springs Drive, Lancaster, PA 17601.